FR Notice Details

Application Information
024
00B
03/05/2021
Riverside
PA
Merck & Co., Inc.
Completed
B-014-2021
False
Notification of Proposed Production Activity; Merck & Co., Inc. (Pharmaceutical Products); Riverside, Pennsylvania

Federal Register, Volume 86 Issue 42 (Friday, March 5, 2021) 
[Federal Register Volume 86, Number 42 (Friday, March 5, 2021)]
[Notices]
[Pages 12907-12908]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-04575]

 

 

-----------------------------------------------------------------------

 

DEPARTMENT OF COMMERCE

 

Foreign-Trade Zones Board

 

[B-14-2021]

 

 

Foreign-Trade Zone (FTZ) 24--Pittston, Pennsylvania; Notification
of Proposed Production Activity; Merck & Co., Inc. (Pharmaceutical
Products); Riverside, Pennsylvania

 

    Merck & Co., Inc. (Merck), submitted a notification of proposed
production activity to the FTZ Board for its facility in Riverside,
Pennsylvania. The notification conforming to the requirements of the
regulations of the FTZ Board (15 CFR 400.22) was received on February
24, 2021.
    Merck already has authority to produce pharmaceutical products
within Subzone 24B. The current request would add finished products and
foreign status materials to the scope of authority. Pursuant to 15 CFR
400.14(b), additional FTZ authority would be limited to the specific
foreign-status materials and specific finished products described in
the submitted notification (as described below) and subsequently
authorized by the FTZ Board.
    Production under FTZ procedures could exempt Merck from customs
duty payments on the foreign-status materials used in export
production. On its domestic sales, for the foreign-status materials/
components noted below and in the existing scope of authority, Merck
would be able to choose the duty rates during customs entry procedures

that apply to PRIMAXIN intermediate (imipenem and cilastatin bulk) and
INVANZ intermediate (ertapenem sodium) (duty-free). Merck would be able
to avoid duty on foreign-status components which become scrap/waste.
Customs duties also could possibly be deferred or reduced on foreign-
status production equipment.
    The materials sourced from abroad include: imipenem input;
cilastatin input; ertapenem sodium input; BIS (2,

 

[[Page 12908]]

 

4-Dichlorophenyl) Chlorophosphate; Bi-Cyclic ADC-13 Ketone; Enol
Phosphate; and, D-Carboxamide (duty rate ranges from duty-free to
6.5%). The request indicates that the materials are subject to duties
under Section 301 of the Trade Act of 1974 (Section 301), depending on
the country of origin. The applicable Section 301 decisions require
subject merchandise to be admitted to FTZs in privileged foreign status
(19 CFR 146.41).
    Public comment is invited from interested parties. Submissions
shall be addressed to the Board's Executive Secretary and sent to:
ftz@trade.gov. The closing period for their receipt is April 14, 2021.
    A copy of the notification will be available for public inspection
in the ``Reading Room'' section of the Board's website, which is
accessible via www.trade.gov/ftz.
    For further information, contact Christopher Wedderburn at
Chris.Wedderburn@trade.gov.

 

    Dated: March 2, 2021.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2021-04575 Filed 3-4-21; 8:45 am]
BILLING CODE 3510-DS-P